CHEBI:18313 - α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide
ChEBI ID CHEBI:18313
ChEBI ASCII Name alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide
Definition A glycotriaosylceramide having α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucose as the trisaccharide component.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:20962, CHEBI:4148, CHEBI:12310, CHEBI:9719, CHEBI:14310, CHEBI:16839, CHEBI:20969, CHEBI:27113, CHEBI:12948
Download Molfile XML SDF
Formula C37H66NO18R
Net Charge 0
Average Mass (excl. R groups) 812.917
Monoisotopic Mass (excl. R groups) 812.42799
SMILES [C@@H]1([C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O[C@@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)O)O)O)O)OC[C@@H]([C@@H](/C=C/CCCCCCCCCCCCC)O)NC(=O)*
Metabolite of Species Details
Mus musculus (NCBI:txid10090) Source: BioModels - MODEL1507180067 See: PubMed
Roles Classification
Biological Role(s): mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
antigen
Any substance that stimulates an immune response in the body, such as through antibody production or by presentation to a T-cell receptor after binding to a major histocompability complex (MHC).
View more via ChEBI Ontology
ChEBI Ontology
Outgoing α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18313) has role antigen (CHEBI:59132)
α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18313) has role mouse metabolite (CHEBI:75771)
α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18313) is a glycotriaosylceramide (CHEBI:36508)
Incoming α-D-Gal-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1ʼ)-N- acylsphingosine (CHEBI:140745) has functional parent α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18313)
β-D-GlcNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1ʼ)-ceramide(d18:1(4E)) (CHEBI:141182) has functional parent α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18313)
α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer(d18:1/26:1(17Z)) (CHEBI:133816) is a α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18313)
α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-N-hexacosanoylceramide (CHEBI:75188) is a α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18313)
IUPAC Name
N-[(2S,3R,4E)-1-{[α-D-galactopyranosyl-(1→4)-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide
Synonyms Sources
α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer JCBN
α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-ceramide ChEBI
α-D-Galp-(1→4)-β-D-Galp-(1→4)-β-D-Glcp-(1↔1')-Cer JCBN
Burkitt's lymphoma antigen, bla-CD77 ChemIDplus
ceramide trihexoside ChEBI
CTH ChEBI
D-Galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide KEGG COMPOUND
Gal-alpha1->4Gal-beta1->4Glc-beta1->1'Cer KEGG COMPOUND
Gal-alpha1->4LacCer KEGG COMPOUND
Gal-α1→4LacCer KEGG COMPOUND
Galα1-4Galβ1-4Glcβ1-1'ceramide ChEBI
Gb3 ChEBI
Gb3Cer KEGG GLYCAN
GbOSe3Cer ChEBI
globoside Gb3Cer (d18:1(4E)) UniProt
globotriaosylceramide ChemIDplus
globotrihexosylceramide ChEBI
Globotriosylceramide KEGG COMPOUND
Trihexosylceramide KEGG COMPOUND
Manual Xrefs Databases
C04737 KEGG COMPOUND
D-GALACTOSYL-14-D-GALACTOSYL-14-D- MetaCyc
G00093 KEGG GLYCAN
View more database links
Registry Number Type Source
71965-57-6 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
11437603 PubMed citation Europe PMC
11525645 PubMed citation Europe PMC
11946769 PubMed citation Europe PMC
12227795 PubMed citation Europe PMC
15113548 PubMed citation Europe PMC
1528196 PubMed citation Europe PMC
16120140 PubMed citation Europe PMC
1724444 PubMed citation Europe PMC
17258170 PubMed citation Europe PMC
17674039 PubMed citation Europe PMC
18176841 PubMed citation Europe PMC
18810447 PubMed citation Europe PMC
19655181 PubMed citation Europe PMC
20424866 PubMed citation Europe PMC
20623712 PubMed citation Europe PMC
2120125 PubMed citation Europe PMC
21252262 PubMed citation Europe PMC
21376640 PubMed citation Europe PMC
2448252 PubMed citation Europe PMC
2456994 PubMed citation Europe PMC
2500499 PubMed citation Europe PMC
2960671 PubMed citation Europe PMC
7691279 PubMed citation Europe PMC
7841803 PubMed citation Europe PMC
Last Modified
05 November 2018